Evofem Biosciences EVFM
OTC EVFM
$0.01 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Evofem Biosciences (EVFM) Other Accumulated Expenses (2014 - 2026)

Updated

Evofem Biosciences (EVFM) posted Other Accumulated Expenses of $11.17 million for Q2 2026, up 47.2% from $7.59 million a year earlier and up 9.2% from the prior quarter.

Analysis

Evofem Biosciences (EVFM) Other Accumulated Expenses (2014 - 2026) Analysis & Trends

At the end of FY2025, Evofem Biosciences' Other Accumulated Expenses came in at $12.02 million, up 63.2% from FY2024.

  • Annual Other Accumulated Expenses has increased for five consecutive years, with a five-year compound annual growth rate of 66.0% (FY2020 to FY2025).
  • In prior years, Evofem Biosciences' Other Accumulated Expenses was $7.36 million in FY2024 (+122.0%), $3.32 million in FY2023 (+15.3%), $2.88 million in FY2022 (+0.4%) and $2.86 million in FY2021 (+200.5%).
  • Quarterly Other Accumulated Expenses has run from a low of $1.41 million in Q1 2022 to a high of $12.02 million in Q4 2025 over five years.
  • On a year-over-year basis, Other Accumulated Expenses has increased in each of the last seven quarters, with growth averaging 101.3% over the last eight quarters.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q3 2025, with growth of 373.7%; the weakest was Q3 2024, with a decline of 51.2%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $10.23 million (Q1 2026), $12.02 million (Q4 2025) and $8.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Evofem Biosciences 1.33 Mn 1.33 Mn 2.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.17 Mn
Mar 31, 2026 10.23 Mn
Dec 31, 2025 12.02 Mn
Sep 30, 2025 8.16 Mn
Jun 30, 2025 7.59 Mn
Mar 31, 2025 7.18 Mn
Dec 31, 2024 7.36 Mn
Sep 30, 2024 1.72 Mn
Jun 30, 2024 3.78 Mn
Mar 31, 2024 3.39 Mn
Dec 31, 2023 3.32 Mn
Sep 30, 2023 3.53 Mn
Jun 30, 2023 3.63 Mn
Mar 31, 2023 3.19 Mn
Dec 31, 2022 2.88 Mn
Sep 30, 2022 5.08 Mn
Jun 30, 2022 2.42 Mn
Mar 31, 2022 1.41 Mn
Dec 31, 2021 2.86 Mn
Sep 30, 2021 2.48 Mn
API Access

Evofem Biosciences Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=EVFM&period=max&api_key=YOUR_API_KEY